-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

The Evolving Field of Hematopoietic Stem Cell Transplantation: The Emerging Role of Cell Therapy

Program: Education Program
Session: The Emerging Role of Targeted Therapies and Cell Therapy in Transplant
Saturday, December 5, 2020, 1:55 PM-2:00 PM

Stephan Mielke, MD

Karolinska Institute & University Hospital, Stockholm, Sweden

Disclosures: Mielke: Celgene/BMS: Honoraria, Other: received via my institution , Speakers Bureau; Novartis: Honoraria, Other: received via my institution, Speakers Bureau; Bellicum: Honoraria, Other: received via my institution, Speakers Bureau; DNA Prime: Honoraria, Other: received via my institution , Speakers Bureau; KIADIS Pharma: Honoraria, Other: received via my institution , Speakers Bureau; Miltenyi: Honoraria, Membership on an entity's Board of Directors or advisory committees, Other: received via my institution , Speakers Bureau; Kite/Gilead: Honoraria, Other: received via my institution , Speakers Bureau.

See more of: The Emerging Role of Targeted Therapies and Cell Therapy in Transplant
See more of: Education Program
Previous Presentation | Next Presentation >>